Old Painkiller, Old Concern: EMA Revisits Metamizole’s Safety

The European Medicines Agency is reviewing the known risk of agranulocytosis in people taking medicines containing the painkiller metamizole, which is approved for use in most of the EU member states but banned in the US, the UK and other countries around the world.

A safety review of metamizole has started in the EU • Source: Shutterstock

More from Europe

More from Geography